NCT06385002View on ClinicalTrials.gov

Effect of Combined Administration of Sevoflurane and Remimazolam on Emergence

NACompletedINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

July 31, 2023

Primary Completion Date

August 31, 2024

Study Completion Date

June 30, 2025

Conditions
Gynecological Surgery
Interventions
DRUG

Remimazolam

After tracheal intubation, the experimental group will maintain oxygen-air (O2-Air) at 2 liters/minute, and remimazolam will be infused at 1.0mg/kg/h, while adjusting the concentration of sevoflurane to maintain the depth of anesthesia with a bispectral index (BIS) of 40-60.

Trial Locations (1)

Unknown

Pusan National University Yangsan Hospital, Yangsan

All Listed Sponsors
lead

Pusan National University Yangsan Hospital

OTHER